BRIEF published on 01/14/2025 at 17:08, 1 year 5 months ago Eckert & Ziegler Partners with Chinese Joint Venture for Actinium-225 Production Clinical Trials Radiopharmaceuticals Licence Agreement Actinium-225 Supply Expansion
BRIEF published on 01/14/2025 at 17:08, 1 year 5 months ago Eckert & Ziegler s'associe à une joint-venture chinoise pour la production d'actinium 225 Essais Cliniques Produits Radiopharmaceutiques Contrat De Licence Actinium 225 Expansion De L'offre
PRESS RELEASE published on 01/14/2025 at 17:03, 1 year 5 months ago EQS-Adhoc: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture Eckert & Ziegler SE signs licence agreement with Chinese joint venture for Ac-225 cyclotron technology, aiming to increase supply of Ac-225 for radiopharmaceutical industry Radiopharmaceutical Industry Eckert & Ziegler SE Licence Agreement Ac-225 Chinese Joint Venture
BRIEF published on 01/13/2025 at 10:05, 1 year 5 months ago Eckert & Ziegler and GlyTherix Expand Collaboration with Actinium-225 Supply Agreement Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Actinium-225 GlyTherix
BRIEF published on 01/13/2025 at 10:05, 1 year 5 months ago Eckert & Ziegler et GlyTherix étendent leur collaboration avec un accord de fourniture d'actinium-225 Eckert & Ziegler Produits Radiopharmaceutiques Thérapie Contre Le Cancer GlyTherix Actinium 225
PRESS RELEASE published on 01/13/2025 at 10:00, 1 year 5 months ago Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement Eckert & Ziegler and GlyTherix extend collaboration with Actinium-225 supply agreement, enhancing cancer therapy access globally Eckert & Ziegler Collaboration Actinium-225 GlyTherix Radiotherapy
BRIEF published on 12/13/2024 at 09:05, 1 year 6 months ago Eckert & Ziegler Seeks Approval for GalliaPharm® in Japan Diagnostic Imaging Regulatory Approval Nuclear Medicine Japanese Market GalliaPharm®
BRIEF published on 12/13/2024 at 09:05, 1 year 6 months ago Eckert & Ziegler demande l'approbation de GalliaPharm® au Japon Marché Japonais Approbation Réglementaire Médecine Nucléaire GalliaPharm® Imagerie Diagnostique
PRESS RELEASE published on 12/13/2024 at 09:00, 1 year 6 months ago Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW Eckert & Ziegler submits GalliaPharm for approval in Japan, expanding access to advanced diagnostic tools like 68Ga-PSMA-11, enhancing precision in oncology imaging Oncology Eckert & Ziegler Diagnostic Imaging Japan Approval GalliaPharm
BRIEF published on 12/05/2024 at 09:35, 1 year 6 months ago Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement Cancer Treatment Precision Medicine Radiopharmaceuticals Supply Agreement Isotopes
Published on 06/22/2026 at 15:58, 1 hour 50 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 2 hours 18 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 2 hours 48 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 3 hours 47 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 3 hours 48 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 17:35, 13 minutes ago Heidrick & Struggles Strengthens Board with Appointment of AI and Talent Leaders Aseem Datar and Leanne Wood
Published on 06/22/2026 at 16:21, 1 hour 27 minutes ago Fuller, Smith & Turner PLC: Share Buyback Programme
Published on 06/22/2026 at 16:05, 1 hour 43 minutes ago ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 2 hours 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 17:45, 3 minutes ago Déclaration des transactions sur actions propres réalisées du 15/06/2026 au 21/06/2026
